Related Experiment Video
Updated: May 28, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.6K
Survey of Diabetes Technology in the Pediatric Inpatient Setting
Abby B Hamilton1, Nitya Rajagopal1, Chloe Ngo2
1OU-TU School of Community Medicine (ABH, NR), Tulsa, OK.
Summary
Hospitals need better policies for diabetes technology in pediatric care. Many lack guidelines for continuous glucose monitors (CGMs) and insulin pumps, impacting patient safety and quality of life.
Area of Science:
- Pediatric Endocrinology
- Health Informatics
- Hospital Administration
Background:
- Diabetes technology, including insulin pumps and continuous glucose monitors (CGMs), significantly enhances the quality of life for children with diabetes.
- Increasing adoption of these technologies necessitates clear hospital policies for safe and effective inpatient use.
Purpose of the Study:
- To evaluate the prevalence of hospital policies for diabetes technology in pediatric inpatient settings.
- To assess the content of existing policies and identify areas for improvement.
Main Methods:
- A survey on diabetes technology use and policies was developed by a multidisciplinary team.
- The survey was distributed to pharmacists in the Pediatric Pharmacy Association in August 2022.
- Descriptive statistics were used to analyze current practices and policies.
Main Results:
- 55% of hospitals allowed CGM use, with 77% having policies; barriers included lack of policy, staff knowledge, and EHR integration.
- Many hospitals did not utilize CGM alarms for glucose level alerts (59%).
- 94% of hospitals allowed insulin pump use with policies, but less than half had specific protocols for pump site failure (46%), and only 60% verified insulin doses.
Conclusions:
- There is a significant need to enhance both the existence and content of hospital policies for continuous glucose monitors and insulin pumps.
- Improved policies are crucial for optimizing the use of diabetes technology in pediatric inpatient care.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
01:15Diabetes: Management and Pharmacotherapy
232
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
01:22Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
01:16Insulin: Dosing Regimen and Adverse Effects
140
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
140
01:15Diabetes: Symptoms, Diagnosis, and Complications
499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
01:30Pulse rhythm
754
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
754